AT9283
- Generic Name
- AT9283
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C19H23N7O2
- CAS Number
- 896466-04-9
- Unique Ingredient Identifier
- XAV9KYN9WL
- Background
AT9283 is an aurora Kinase inhibitor developed by Astex Therapeutics for the treatment of cancer. It was discovered and developed internally using Astex’s fragment-based drug discovery platform, Pyramid.
- Indication
Investigated for use/treatment in cancer/tumors (unspecified), leukemia (myeloid), and solid tumors.
- Associated Conditions
- -
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath